Generalized bleeding following the treatment of prostatic carcinoma with testosterone and radioactive phosphorus.
D000230:Adenocarcinoma / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010759:Phosphorus Isotopes / Q000009:adverse effects* / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000009:adverse effects* / Q000627:therapeutic use
D010759:Phosphorus Isotopes; D013739:Testosterone